Huntington disease: natural history, biomarkers and prospects for therapeutics

Christopher A Ross, Elizabeth H Aylward, Edward J Wild, Douglas R Langbehn, Jeffrey D Long, John H Warner, Rachael I Scahill, Blair R Leavitt, Julie C Stout, Jane S Paulsen, Ralf Reilmann, Paul G Unschuld, Alice Wexler, Russell L Margolis, Sarah J Tabrizi, Christopher A Ross, Elizabeth H Aylward, Edward J Wild, Douglas R Langbehn, Jeffrey D Long, John H Warner, Rachael I Scahill, Blair R Leavitt, Julie C Stout, Jane S Paulsen, Ralf Reilmann, Paul G Unschuld, Alice Wexler, Russell L Margolis, Sarah J Tabrizi

Abstract

Huntington disease (HD) can be seen as a model neurodegenerative disorder, in that it is caused by a single genetic mutation and is amenable to predictive genetic testing, with estimation of years to predicted onset, enabling the entire range of disease natural history to be studied. Structural neuroimaging biomarkers show that progressive regional brain atrophy begins many years before the emergence of diagnosable signs and symptoms of HD, and continues steadily during the symptomatic or 'manifest' period. The continued development of functional, neurochemical and other biomarkers raises hopes that these biomarkers might be useful for future trials of disease-modifying therapeutics to delay the onset and slow the progression of HD. Such advances could herald a new era of personalized preventive therapeutics. We describe the natural history of HD, including the timing of emergence of motor, cognitive and emotional impairments, and the techniques that are used to assess these features. Building on this information, we review recent progress in the development of biomarkers for HD, and potential future roles of these biomarkers in clinical trials.

References

    1. Brain. 2002 Aug;125(Pt 8):1815-28
    1. Neurology. 2005 Sep 27;65(6):941-3
    1. Neuropsychologia. 2010 Jan;48(2):549-57
    1. J Clin Invest. 2012 Oct;122(10):3731-6
    1. Prion. 2013 May-Jun;7(3):221-8
    1. Lancet Neurol. 2011 Jan;10(1):31-42
    1. Cogn Behav Neurol. 2005 Jun;18(2):102-7
    1. Ann Neurol. 1997 May;41(5):689-92
    1. J Neurol. 2009 Feb;256(2):203-12
    1. Mov Disord. 2011 Oct;26(12):2267-73
    1. J Neurol Neurosurg Psychiatry. 2008 Feb;79(2):130-5
    1. J Neurol Neurosurg Psychiatry. 2012 Jul;83(7):687-94
    1. Brain Res Bull. 2010 May 31;82(3-4):201-7
    1. Neurobiol Dis. 2010 Dec;40(3):544-54
    1. Clin Genet. 2004 Apr;65(4):267-77
    1. Lancet Neurol. 2011 Jun;10(6):573-90
    1. Neurology. 1992 Sep;42(9):1791-7
    1. Eur J Neurol. 2003 Jul;10(4):443-4
    1. J Clin Exp Neuropsychol. 2002 Apr;24(2):133-45
    1. Mov Disord. 2000 May;15(3):552-60
    1. Brain. 2008 Jan;131(Pt 1):196-204
    1. Anal Biochem. 2009 Dec 1;395(1):8-15
    1. Biol Psychiatry. 2006 Jan 1;59(1):57-63
    1. Mov Disord. 2007 Sep 15;22(12):1783-9
    1. AJNR Am J Neuroradiol. 2004 Nov-Dec;25(10):1715-21
    1. Nat Rev Neurol. 2010 Mar;6(3):131-44
    1. Am J Med Genet. 2001 Jul 8;105(5):399-403
    1. Brain. 2007 Nov;130(Pt 11):2858-67
    1. Brain. 2009 Jun;132(Pt 6):1624-32
    1. J Neurol Neurosurg Psychiatry. 2010 Jul;81(7):756-63
    1. AJNR Am J Neuroradiol. 2010 Nov;31(10):1807-12
    1. Neuroimage. 2009 Jul 15;46(4):958-66
    1. Cortex. 2013 Nov-Dec;49(10):2661-73
    1. Hum Brain Mapp. 2014 Mar;35(3):792-809
    1. Hum Mol Genet. 2005 Oct 1;14(19):2871-80
    1. Lancet Neurol. 2013 Jul;12(7):637-49
    1. Genet Epidemiol. 2008 Jul;32(5):445-53
    1. Psychiatry Res. 2012 Aug-Sep;203(2-3):166-74
    1. Mol Ther. 2011 Dec;19(12):2178-85
    1. Neurology. 2010 Apr 13;74(15):1208-16
    1. Neurology. 2006 Jan 24;66(2):250-2
    1. J Clin Neurol. 2013 Jan;9(1):21-5
    1. Neurobiol Dis. 2012 Jun;46(3):625-34
    1. Biochem Biophys Res Commun. 2012 Aug 3;424(3):404-8
    1. J Neurol. 2009 Jan;256(1):109-14
    1. AJNR Am J Neuroradiol. 2010 Oct;31(9):1675-81
    1. Brain. 2012 Apr;135(Pt 4):1165-79
    1. Hum Mol Genet. 2006 Oct 1;15(19):2856-68
    1. Mov Disord. 2012 Dec;27(14):1714-7
    1. J Neurol Neurosurg Psychiatry. 2010 Mar;81(3):257-62
    1. Lancet Neurol. 2013 Feb;12(2):207-16
    1. Neurology. 1981 Oct;31(10):1333-5
    1. J Neurol Neurosurg Psychiatry. 2011 Apr;82(4):405-10
    1. AJNR Am J Neuroradiol. 2012 May;33(5):884-9
    1. Lancet Neurol. 2012 Jan;11(1):42-53
    1. Proc Natl Acad Sci U S A. 2005 Apr 19;102(16):5820-5
    1. Ann Neurol. 2004 Jun;55(6):879-83
    1. Arch Neurol. 2012 Jul;69(7):887-93
    1. Brain Imaging Behav. 2011 Sep;5(3):171-80
    1. Trends Biochem Sci. 2006 Sep;31(9):533-40
    1. J Neuropsychiatry Clin Neurosci. 2012 Winter;24(1):53-60
    1. CNS Neurosci Ther. 2009 Winter;15(1):1-11
    1. Expert Opin Med Diagn. 2012 Sep;6(5):371-5
    1. Mov Disord. 2006 Sep;21(9):1317-25
    1. J Neurol Sci. 2011 Aug 15;307(1-2):60-8
    1. Eur J Neurol. 2008 Nov;15(11):1180-90
    1. Science. 2001 May 25;292(5521):1552-5
    1. Mov Disord. 1996 Mar;11(2):136-42
    1. Brain. 2007 Nov;130(Pt 11):2845-57
    1. Lancet. 1994 Jun 18;343(8912):1580
    1. Mov Disord. 2012 Feb;27(2):272-6
    1. Exp Neurol. 2009 Apr;216(2):272-7
    1. Exp Neurol. 2012 Sep;237(1):191-8
    1. Neuropsychology. 2011 Jan;25(1):1-14
    1. Neurology. 2014 Mar 11;82(10):850-7
    1. Hum Genet. 2012 Dec;131(12):1833-40
    1. Lancet Neurol. 2011 Jan;10(1):83-98
    1. Expert Opin Med Diagn. 2008 Jan;2(1):47-62
    1. Mov Disord. 2005 Mar;20(3):293-7
    1. Curr Treat Options Neurol. 2012 Feb 8;:
    1. Neurobehav Toxicol Teratol. 1983 Nov-Dec;5(6):605-9
    1. Cell. 2000 Mar 31;101(1):57-66
    1. Neurology. 2010 Dec 14;75(24):2150-60
    1. Neurology. 1998 May;50(5):1357-65
    1. Brain. 2008 Nov;131(Pt 11):2851-9
    1. Neurology. 2013 May 21;80(21):1934-41
    1. Brain. 2008 Apr;131(Pt 4):1057-68
    1. PLoS One. 2012;7(2):e29522
    1. JAMA Neurol. 2013 Dec;70(12):1520-30
    1. Mov Disord. 2010 Dec 15;25(16):2858-62
    1. Lancet Neurol. 2009 Sep;8(9):791-801
    1. J Huntingtons Dis. 2013;2(4):517-26
    1. Neuron. 2009 Oct 15;64(1):21-4
    1. Clin Genet. 2000 Jul;58(1):50-6
    1. J Clin Invest. 2013 Sep;123(9):4076-88
    1. J Neurol. 2008 Nov;255(11):1785-91
    1. Neurology. 2010 Nov 9;75(19):1702-10
    1. J Cell Mol Med. 2011 Mar;15(3):555-71
    1. Ann Neurol. 1997 May;41(5):646-53
    1. J Neurol Neurosurg Psychiatry. 2011 Dec;82(12):1409-12
    1. Proc Natl Acad Sci U S A. 2011 Oct 11;108(41):17141-6
    1. J Nucl Med. 2006 Feb;47(2):215-22
    1. Hum Brain Mapp. 2013 Jul;34(7):1625-35
    1. Neurology. 2003 May 27;60(10):1615-20
    1. Expert Rev Neurother. 2008 Dec;8(12):1779-81
    1. Psychiatry Res. 2005 Oct 30;140(1):55-62
    1. Eur J Nucl Med Mol Imaging. 2012 Jun;39(6):1030-6
    1. Neurosci Biobehav Rev. 2013 Mar;37(3):480-90
    1. Neurology. 1979 Jan;29(1):1-3
    1. J Neurol Sci. 2005 Dec 15;239(1):11-9
    1. Neurology. 2006 Apr 11;66(7):1016-20
    1. Neurobiol Dis. 2012 Jan;45(1):83-98
    1. Braz J Med Biol Res. 2006 Aug;39(8):1129-36
    1. Neuropsychologia. 2007 Apr 9;45(8):1767-76
    1. Science. 2010 Apr 30;328(5978):636-9
    1. Neurology. 2001 Sep 11;57(5):920-4
    1. J Neuropsychiatry Clin Neurosci. 2010 Spring;22(2):196-207
    1. Mov Disord. 2011 Dec;26(14):2544-51
    1. Cell. 1993 Mar 26;72(6):971-83
    1. J Neurol Neurosurg Psychiatry. 2008 Aug;79(8):874-80
    1. Biol Psychiatry. 2012 May 1;71(9):822-8
    1. Neurosci Lett. 2012 Apr 18;514(2):204-9
    1. Hum Brain Mapp. 2013 Mar;34(3):519-29
    1. J Exp Med. 2008 Aug 4;205(8):1869-77
    1. Ann Neurol. 2003 Oct;54(4):488-93
    1. Mov Disord. 2012 Sep 15;27(11):1379-86
    1. Ann Neurol. 2011 Oct;70(4):532-40
    1. Mov Disord. 2010 Jul 15;25(9):1163-9
    1. Mov Disord. 2012 Jun;27(7):895-902
    1. PLoS Curr. 2010 Dec 29;2:RRN1205
    1. Hum Brain Mapp. 2013 Sep;34(9):2141-53
    1. Am J Med Genet B Neuropsychiatr Genet. 2011 Dec;156B(7):751-63
    1. J Clin Invest. 2011 Feb;121(2):484-92
    1. J Nucl Med. 2001 Nov;42(11):1591-5
    1. Neurology. 1997 Feb;48(2):394-9
    1. Mol Cell Proteomics. 2009 Mar;8(3):451-66
    1. Am J Med Genet B Neuropsychiatr Genet. 2010 Mar 5;153B(2):397-408
    1. Neurology. 2001 Sep 25;57(6):1025-8
    1. Neuroimage. 2011 May 15;56(2):788-96
    1. Neuroimage. 2010 Feb 15;49(4):2995-3004
    1. Proc Natl Acad Sci U S A. 2004 Mar 9;101(10):3498-503

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir